Bristol-Myers Squibb Company Savings and Investment Program
Active. The plan filed its annual report for the 2025 plan year.
- Plan number
- 002Employer EIN 22-0790350
- Participants (2025)
- 34,444
- Net assets (2025)
- $12.7 billion
- Plan administrator
- Bristol-Myers Squibb Company Savings Plan Committee
Route 206 Province Line Road
Princeton, NJ 08543
(609) 252-4621As filed for 2025 - In effect since
- January 1, 1971
Plans merged into this one: Bristol-Myers Squibb Retirement Income Plan (2022); Celgene Corporation 401(k) Plan (2020); Amylin Pharmaceuticals, LLC 401(k) Plan (2013).
Earlier sponsor: Bristol-Myers Squibb Company Senior VP, Total Rewards (2020–2021).
Earlier plan names: Bristol-Myers Squibb Savings and Investment Program; Bristol-Myers Squibb Savings and Invest Investment Program.
Year by year, 2009 to 2025
| Plan year | Participants | Net assets | Recordkeeper |
|---|---|---|---|
| 2025 | 34,444 | $12.7 billion | not listed |
| 2024 | 34,900 | $11.6 billion | not listed |
| 2023 | 33,339 | $10.3 billion | not listed |
| 2022 | 34,651 | $9.0 billion | not listed |
| 2021 | 32,316 | $10.9 billion | not listed |
| 2020 | 23,172 | $8.4 billion | not listed |
| 2019 | 21,500 | $6.8 billion | not listed |
| 2018 | 21,619 | $5.5 billion | not listed |
| 2017 | 21,507 | $6.0 billion | not listed |
| 2016 | 22,125 | $5.2 billion | not listed |
| 2015 | 22,558 | $5.1 billion | not listed |
| 2014 | 22,998 | $5.0 billion | not listed |
| 2013 | 24,540 | $4.9 billion | not listed |
| 2012 | 21,853 | $3.9 billion | not listed |
| 2011 | 23,345 | $3.6 billion | not listed |
| 2010 | 23,328 | $3.2 billion | not listed |
| 2009 | 35,537 | $2.8 billion | not listed |